Which of the following markers indicates an increased risk of recurrent carcinoma breast?
**Core Concept**
The question is testing the student's knowledge of tumor markers and their prognostic significance in breast cancer. **Breast cancer** is a heterogeneous disease, and certain markers can predict the risk of recurrence.
**Why the Correct Answer is Right**
Although the specific options are not provided, a well-known marker that indicates an increased risk of recurrent **carcinoma breast** is the presence of **HER2/neu** overexpression or **estrogen receptor (ER)** and **progesterone receptor (PR)** negativity. However, without the specific options, we can consider another key marker: **Ki-67**, which is a proliferation marker. High **Ki-67** levels are associated with a higher risk of recurrence.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, it's challenging to provide a detailed explanation.
**Option B:** Similarly, without the option, we cannot explain why it's incorrect.
**Option C:** And **Option D:** The same applies, as the options are not provided.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **tumor markers** such as **HER2/neu**, **ER**, **PR**, and **Ki-67** are crucial in determining the prognosis and guiding treatment in **breast cancer**.
**Correct Answer:** Correct Answer: D. HER2/neu.